Ordinary Rebalance | Solactive Global Healthcare Exposure Index | Effective Date 10th May 2023
In the ordinary rebalance, the following index composition will be implemented effective open 10.05.2023:
| ABBVIE INC |
| AGC INC |
| ALFRESA HOLDINGS CORP ORD |
| AMGEN INC |
| ASAHI KASEI CORP |
| ASTELLAS PHARMA INC |
| BRISTOL-MYERS SQUIBB CO |
| CANON INC |
| CVS HEALTH CORP |
| GILEAD SCIENCES INC |
| GSK PLC |
| JOHNSON & JOHNSON |
| MEIJI HOLDINGS CO LTD |
| MERCK & CO. INC. |
| NISSAN CHEMICAL CORP |
| NITTO DENKO CORP |
| NOVARTIS AG |
| PEARSON PLC |
| PFIZER INC |
| RECKITT BENCKISER GROUP PLC |
| ROCHE HOLDING AG |
| SANOFI SA |
| SANTEN PHARMACEUTICAL CO LTD ORD |
| SBI HOLDINGS INC ORD |
| SEKISUI CHEMICAL CO LTD ORD |
| SOMPO HOLDINGS INC |
| STOCKLAND |
| SUMITOMO CHEMICAL CO LTD |
| TAKEDA PHARMACEUTICAL |
| TOSOH CORP |